Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy
- 1 October 2001
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (2), 435-441
- https://doi.org/10.1016/s0360-3016(01)01645-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- NAT and blood safety: what is the paradigm?Transfusion, 2000
- Erythropoietin‐induced rheological changes of rat erythrocytesBritish Journal of Haematology, 2000
- Analysis of the Cost Effectiveness of Concurrent Cisplatin-Based Chemoradiation in Cervical Cancer: Implications from Five Randomized TrialsGynecologic Oncology, 2000
- Universal WBC reductionTransfusion, 2000
- What are cancer patients willing to pay for prophylactic epoetin alfa?Cancer, 1998
- A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurityTransfusion, 1995
- Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trialThe Journal of Pediatrics, 1995
- IgA anaphylactic transfusion reactionsTransfusion Medicine Reviews, 1995
- A Cost-Effectiveness Analysis of Epoetin Usage for Patients with AIDSPharmacoEconomics, 1993
- Changes of blood oxygen affinity in different CPD solutions during liquid storageTransfusion, 1981